surmount-1 tirzepatide non-diabetic obesity weight loss FDA Grants a New Indication for Management Tirzepatide (ZEPBOUND) Approved for Chronic
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5






















